Efficacy and safety of Gemogenovatucel-T (Vigil) immunotherapy for advanced ovarian carcinoma: A systematic review and meta-analysis of randomized controlled trials

In recent years, many clinical trials have shown the safety and efficacy of Gemogenovatucel-T (Vigil) in the treatment of advanced OC patients. The purpose of this study was to explore the safety and efficacy of Gemogenovatucel-T (Vigil) in the first-line maintenance of advanced ovarian carcinoma ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yixin, Zhang, Li, Zhao, Yuli, Wang, Sen, Feng, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634109/
https://www.ncbi.nlm.nih.gov/pubmed/36338747
http://dx.doi.org/10.3389/fonc.2022.945867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634109/
https://www.ncbi.nlm.nih.gov/pubmed/36338747
http://dx.doi.org/10.3389/fonc.2022.945867

Ejemplares similares